Dr. Subauste is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Medicine-Infectious Diseases & HIV Medicine
Cleveland, OH 44106Phone+1 216-844-7892Fax+1 216-368-2034
Summary
- Carlos Subauste, MD is an Internist and Infectious Disease specialist based in Cleveland, OH. He completed his Infectious Disease fellowship at Stanford Health Care-Sponsored Stanford University after his Internal Medicine residency at Southern Illinois University. He is a graduate of Cayetano Heredia University. Dr. Subauste has published a series of research papers focusing on host-pathogen interactions using Toxoplasma gondii as a model, the development of novel approaches to treat toxoplasmosis, the role of CD40 in retinal inflammation and diabetic retinopathy. Dr. Subauste has developed novel strategies to inhibit inflammatory disorders. Dr. Subauste is moving his research endeavors to the translational application of his findings for the treatment of important diseases in humans.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1988 - 1992
- Southern Illinois UniversityResidency, Internal Medicine, 1984 - 1987
- Cayetano Heredia UniversityClass of 1983
Certifications & Licensure
- CA State Medical License 1988 - Present
- OH State Medical License 1997 - 2026
- IL State Medical License 1984 - 1990
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A Simplified Method for Isolation and Culture of Retinal Pigment Epithelial Cells from Adult Mice.Alyssa Hubal, Amelia Pfaff, Sarah Vos, Mala Upadhyay, Vera Bonilha
Journal of Visualized Experiments. 2024-05-24 - 4 citationsAdvanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy.Jose-Andres C Portillo, Amelia Pfaff, Sarah Vos, Matthew Weng, Ram H Nagaraj
Cells. 2024-02-29 - 1 citationsAnimal Models for Toxoplasma gondii Infection.Carlos S Subauste, Alyssa Hubal
Current Protocols. 2023-09-01
Journal Articles
- Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cellsJose-Andres C Portillo, Jin-Sang Yu, Sarah Vos, Reena Bapputty, Yalitza Lopez Corcino, Alyssa Hubal, Jad Daw, Sahil Arora, Wenyu Sun, Zheng-Rong Lu, Carlos S Subauste, Diabetologia, 8/3/2022
Press Mentions
- Scientists Find Therapeutic Target for Diabetes-Related BlindnessMarch 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: